Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CEO, Director
-
Issuer Symbol
-
BEAM on Nasdaq
John M. Evans - trading volume in the past year for Beam Therapeutics Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
986,667 |
$28,613,343 |
$29.00 |
30 Jan 2026 |
Direct |
|
|
| Stock Option (Right to Buy) |
180,000 |
$3,782,000 |
$24.40 |
31 Jan 2026 |
Direct |
Common Stock |
|
| Common Stock |
103,000 |
$2,855,160 |
$27.72 |
29 Jan 2026 |
By John M. Evans, III 2018 Irrevocable Trust |
|
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.